LeMaitre Vascular, Inc.
LMAT
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 219.86M | 213.03M | 205.62M | 199.89M | 193.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 219.86M | 213.03M | 205.62M | 199.89M | 193.48M |
| Cost of Revenue | 68.96M | 67.45M | 66.41M | 67.06M | 66.44M |
| Gross Profit | 150.90M | 145.58M | 139.21M | 132.83M | 127.05M |
| SG&A Expenses | 83.00M | 79.59M | 76.62M | 74.76M | 72.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 167.61M | 163.42M | 159.98M | 159.00M | 156.29M |
| Operating Income | 52.26M | 49.61M | 45.64M | 40.89M | 37.20M |
| Income Before Tax | 56.88M | 54.17M | 49.44M | 44.26M | 39.48M |
| Income Tax Expenses | 12.84M | 12.85M | 11.76M | 10.30M | 9.37M |
| Earnings from Continuing Operations | 44.04 | 41.32 | 37.68 | 33.95 | 30.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.04M | 41.32M | 37.68M | 33.95M | 30.11M |
| EBIT | 52.26M | 49.61M | 45.64M | 40.89M | 37.20M |
| EBITDA | 61.93M | 59.24M | 55.24M | 50.44M | 46.71M |
| EPS Basic | 1.96 | 1.84 | 1.69 | 1.52 | 1.35 |
| Normalized Basic EPS | 1.58 | 1.51 | 1.38 | 1.25 | 1.12 |
| EPS Diluted | 1.93 | 1.82 | 1.66 | 1.50 | 1.33 |
| Normalized Diluted EPS | 1.56 | 1.49 | 1.37 | 1.23 | 1.11 |
| Average Basic Shares Outstanding | 89.81M | 89.58M | 89.36M | 89.12M | 88.87M |
| Average Diluted Shares Outstanding | 91.03M | 90.59M | 90.24M | 89.96M | 89.67M |
| Dividend Per Share | 0.64 | 0.62 | 0.60 | 0.58 | 0.56 |
| Payout Ratio | 32.65% | 33.63% | 35.60% | 38.11% | 41.35% |
